Načítá se...
Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency
Tafazzin is the mitochondrial enzyme that catalyzes transacylation between a phospholipid and a lysophospholipid in remodeling. Mutations in tafazzin cause Barth syndrome, a potentially life-threatening disease with the major symptom of cardiomyopathy. In the tafazzin-deficient heart, cardiolipin (C...
Uloženo v:
| Vydáno v: | Biochemistry |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893435/ https://ncbi.nlm.nih.gov/pubmed/29557170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.biochem.8b00042 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|